NCT03530007 is a Phase 2, PHASE3 clinical trial of Normal saline in Shivering, sponsored by Assiut University.

Who is sponsoring NCT03530007?

NCT03530007 is sponsored by Assiut University.

What drugs are being tested in NCT03530007?

Interventions in NCT03530007: Normal saline, Ondansetron 4 MG, Ondansetron 8mg.

What condition does NCT03530007 study?

NCT03530007 studies Shivering, Ondansetron.

Is NCT03530007 still recruiting?

NCT03530007 is currently status unknown. Last updated 21 May 2018.

Last reviewed 2018-05-21 · How we verify

NCT03530007

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anti-shivering Effect of Ondansetron

Status unknown Phase 2, PHASE3 Last updated 21 May 2018

What this trial tests

Phase 2, PHASE3 trial testing Normal saline in Shivering in 120 participants. Status unknown.

Timeline

15 May 2018

Primary endpoint
15 August 2018

15 September 2018

Quick facts

Lead sponsor	Assiut University
Phase	Phase 2, PHASE3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	120
Start date	15 May 2018
Primary completion	15 August 2018
Estimated completion	15 September 2018

Drugs / interventions tested

Normal saline
Ondansetron 4 MG — full drug profile →
Ondansetron 8mg — full drug profile →

Conditions studied

Shivering — all drugs for Shivering →
Ondansetron — all drugs for Ondansetron →

Sponsor

Assiut University

Who can join

Adults 18 to 60, any sex, with Shivering or Ondansetron. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Shivering is one of the most frequent complications occurring during or after spinal anesthesia with many side effects. The aim of the present study was to compare between two different doses of ondansetron for anti-shivering effect

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Normal saline

Trials testing the same drug.

NCT06406829 — Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy · NA · not yet recruiting
NCT07370181 — Ketamine Irrigation Analgesia in Laparoscopic Cholecystectomy · Phase 3 · not yet recruiting
NCT05450328 — Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation · Phase 2 · not yet recruiting
NCT07101367 — A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Under · Phase 1, PHASE2 · not yet recruiting
NCT07345715 — Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy · NA · recruiting

Other recruiting trials for Shivering

Currently open trials in the same condition.

NCT07511491 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section · NA · recruiting
NCT07489742 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy · NA · recruiting
NCT06708169 — Effect of Preemptive Education on the Incidence of Maternal Intraoperative Shivering in Elective Cesarean Delivery · NA · recruiting
NCT07154849 — Comparative Study Between the Efficacy of Intravenous Hydrocortisone and Intravenous Dexmedetomidine for Prevention of P · Phase 4 · recruiting
NCT05765162 — Safe Brain Initiative, Operationalizing Precision Anaesthesia · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03530007 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 21 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03530007.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing